Emily Gardner
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Cellular transport and secretion 4
- Microtubule and mitosis dynamics 3
- Oncology 8
- Lung Cancer Research Studies 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Lois M. MulliganMargaret A. PonderCatherine S. HealeyCharis EngJohn B. KwokSara MoleDonald R. LoveBruce A.J. Ponder
- Journals
- Human Molecular Genetics (6 papers)Molecular Carcinogenesis (2 papers)Nucleic Acids Research (2 papers)Genomics (2 papers)Nature Genetics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Emily Gardner
30 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Endocrinology, Diabetes and Metabolism 1.3k
- Oncology 812
- Cancer Research 381
- Neurology 360
- Genetics 647
Countries citing papers authored by Emily Gardner
This map shows the geographic impact of Emily Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Gardner more than expected).
Fields of papers citing papers by Emily Gardner
This network shows the impact of papers produced by Emily Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Gardner. The network helps show where Emily Gardner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Gardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2021 | 36 | |
| 5 | 1994 | 394 | |
| 6 | 1994 | 495 | |
| 7 | 1994 | 7 | |
| 8 | 1994 | 19 | |
| 9 | Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Hit paper breakdown → | 1993 | 1446 |
| 10 | 1993 | 76 | |
| 11 | 1992 | 7 | |
| 12 | 1992 | 1 | |
| 13 | 1992 | 3 | |
| 14 | A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A. | 1992 | 1 |
| 15 | EXTENDING THE GENETIC-MAP OF THE PERICENTROMERIC REGION OF CHROMOSOME-10 | 1991 | 1 |
| 16 | IS THE RET PROTOONCOGENE A CANDIDATE FOR THE MEN2 GENE | 1991 | 6 |
| 17 | 1991 | 1 | |
| 18 | 1991 | 9 | |
| 19 | 1990 | 16 | |
| 20 | 1988 | 18 |
About Emily Gardner
Emily Gardner is a scholar working on Cell Biology, Oncology, Pathology and Forensic Medicine, Physiology and Molecular Biology, having authored 30 papers that have together received 2.8k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), DNA Repair Mechanisms (4 papers), Cellular transport and secretion (4 papers), Lysosomal Storage Disorders Research (4 papers), Microtubule and mitosis dynamics (3 papers), Lung Cancer Research Studies (3 papers), Cancer-related Molecular Pathways (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Oncology (812 citations), Cancer Research (381 citations), Neurology (360 citations) and Genetics (647 citations). Emily Gardner has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Lois M. Mulligan, Margaret A. Ponder, Catherine S. Healey, Charis Eng, John B. Kwok, Sara Mole, Donald R. Love, Bruce A.J. Ponder, Laura Papi and Håkan Telenius. Their work appears in journals such as Human Molecular Genetics, Molecular Carcinogenesis, Nucleic Acids Research, Genomics and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.